Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Download All
Explore expert-guided education on the use of novel therapies for patients with nonmetastatic hormone-sensitive and castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer with a webcast of a live meeting, downloadable slides, a podcast, and a focused commentary.
Daniel W. Lin, MD
Alicia K. Morgans, MD, MPH
David F. Penson, MD, MPH

Downloadable Slidesets

Download this slideset, in which experts review contemporary disease classifactions in prostate cancer, key considerations in selecting androgen deprivation therapy, and emerging areas of research.

Daniel W. Lin, MD Released: September 10, 2021

Download this slideset to learn how experts approach treatment for patients with nmCRPC.

David F. Penson, MD, MPH Released: September 10, 2021

Download this slideset to learn how experts approach treatment for patients with mHSPC.

Alicia K. Morgans, MD, MPH Released: September 10, 2021

Download this short summary slideset of takeaway points from a live presentation on current clinical guidance and key data on the optimal use of androgen deprivation therapy for nonmetastatic or metastatic prostate cancer.

Daniel W. Lin, MD Alicia K. Morgans, MD, MPH David F. Penson, MD, MPH Released: September 20, 2021

On-Demand Webcast

In this interactive on-demand webcast, expert faculty members discuss current clinical guidance and key data on the optimal use of GnRH agonists and antagonists, androgen receptor inhibitors, and other treatments for nonmetastatic or metastatic prostate cancer.

Daniel W. Lin, MD Alicia K. Morgans, MD, MPH David F. Penson, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: October 6, 2021 Expired: October 5, 2022

Podcast

Listen to experts answer audience questions from a live CCO webinar focused on current clinical guidance and key data on the optimal use of GnRH agonists and antagonists, androgen receptor inhibitors, and other treatments for nonmetastatic or metastatic prostate cancer.

Released: October 7, 2021

ClinicalThought

In this commentary, 3 prostate cancer experts discuss recent advances in treating patients with prostate cancer, including use of GnRH antagonists and androgen receptor inhibitors and the management of patients with comorbidities.

Daniel W. Lin, MD Alicia K. Morgans, MD, MPH David F. Penson, MD, MPH Released: November 2, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Astellas
Bayer HealthCare Pharmaceuticals Inc.
Myovant Sciences Ltd.
Pfizer, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue